Aug 22, 2016 at 14:26 | Source:
Jefferies is bullish on small and midcap pharma names which have differentiated portfolio with a cautious on largecaps. Earnings downgrade is expected to continue for the sector with a 10 percent downgrade possible in next 12 months.
Aug 19, 2016 at 18:25 | Source:
According to Skymet Weather, the initial surge in the monsoon rains can be attributed to the transition of El Nino into the neutral phase.
Aug 12, 2016 at 22:36 | Source: PTI
International ratings agency Standard & Poor's (S&P) on Friday lowered its long-term issuer credit rating on Union Bank of India (UBI) to 'BB+' from 'BBB-', citing weak asset quality, but retained a stable outlook on the state-run lender.
Aug 10, 2016 at 09:12 | Source:
Nomura downgrades stock to neutral with target cut to Rs 1778 from Rs 1873 per share. It expects price to equity valuation to remain above 20 times. It sees substantial improvement in US pipeline over next 12-18 months.
Aug 09, 2016 at 13:22 | Source:
CLSA has downgraded it sell from outperform. The brokerage firm has also cut target to Rs 94 from Rs137 per share. It warns that burden of spectrum may weighing on earnings.
Aug 09, 2016 at 09:13 | Source:
Here are brokerage firms views on six stocks. Motilal downgrades Hero MotoCorp to neutral from buy given rich valuations. Target for the stock is at Rs 3666 per share. It says volume growth drives revenue as adverse mix dragged realisations.
Aug 08, 2016 at 10:09 | Source:
Macquarie has downgraded it to neutral from outperform and reduced target price to Rs 1015 versus Rs 1350 per share. It says Ankleshwar facility receiving under import alert may lead to multiples falling under pressure in the near term. However, it remains bullish on the stock for long term.
Aug 04, 2016 at 09:41 | Source:
Credit Suisse feels Lupin is trading at high end of historical valuations (23x FY18 EPS) and has low margin of safety with high concentration risk.
Aug 02, 2016 at 15:22 | Source:
"With valuations at 4x FY18 price-to-book for 25 percent normalised return on equity, we find the stock expensive and downgrade it to underperform (from neutral)," the brokerage house says.
Aug 02, 2016 at 08:49 | Source:
Credit Suisse has downgraded Ashok Leyland to underperform as commercial vehicle volume may disappoint going forward. Target is cut to Rs 77 per share and FY17 volume growth is lowered to 12 percent from 22 percent.
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.